INTECH Investment Management’s Integra LifeSciences IART Stock Holding History

INTECH Investment Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$639K	Sell	35,554 -21,346	-38%	-$299K	0.01%	1235
2026 Q1	$536K	Buy	56,900 +29,622	+109%	+$325K	0.01%	1307
2025 Q4	$339K	Sell	27,278 -477	-2%	-$6.34K	﹤0.01%	1699
2025 Q3	$398K	Sell	27,755 -3,894	-12%	-$53.3K	﹤0.01%	1689
2025 Q2	$388K	Sell	31,649 -2,656	-8%	-$38.6K	﹤0.01%	1749
2025 Q1	$754K	Buy	34,305 +10,192	+42%	+$240K	0.01%	1374
2024 Q4	$547K	Buy	24,113 +11,174	+86%	+$244K	0.01%	1512
2024 Q3	$235K	Buy	+12,939	New	+$300K	﹤0.01%	1644

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

INTECH Investment Management's IART Position: Q2 2026 in Review

INTECH Investment Management reduced its Integra LifeSciences (IART) stake by 38% in Q2 2026, selling an estimated $299K and leaving 35,554 shares worth $639K. The position accounts for 0.01% of the portfolio, ranked #1235.

INTECH Investment Management first reported a position in IART in Q3 2024 and has held it in 8 quarters since. The position peaked at $754K in Q1 2025. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

INTECH Investment Management held 35,554 shares of Integra LifeSciences worth $639K as of Q2 2026.
INTECH Investment Management sold 21,346 Integra LifeSciences shares in Q2 2026, an estimated $299K.
Integra LifeSciences made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1235 holding.
INTECH Investment Management first reported a position in Integra LifeSciences in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Integra LifeSciences position peaked at $754K in Q1 2025.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.